Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Critical Care
Volume 2015, Article ID 542490, 5 pages
http://dx.doi.org/10.1155/2015/542490
Case Report

The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity

Department of Medicine, New York University School of Medicine, Woodhull Medical and Mental Health Center, 760 Broadway, Brooklyn, NY 11206, USA

Received 27 September 2015; Revised 1 December 2015; Accepted 2 December 2015

Academic Editor: Chiara Lazzeri

Copyright © 2015 Jose Orsini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Dresen, N. Ferreirós, M. Pütz, F. Westphal, R. Zimmermann, and V. Auwärter, “Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds,” Journal of Mass Spectrometry, vol. 45, no. 10, pp. 1186–1194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Castaneto, D. A. Gorelick, N. A. Desrosiers, R. L. Hartman, S. Pirard, and M. A. Huestis, “Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications,” Drug and Alcohol Dependence, vol. 144, pp. 12–41, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. F. Hoffman, A. C. Riegel, and C. R. Lupica, “Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus,” The European Journal of Neuroscience, vol. 18, no. 3, pp. 524–534, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Koethe, C. W. Gerth, M. A. Neatby et al., “Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness,” Schizophrenia Research, vol. 88, no. 1–3, pp. 142–150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. M. Berlach, Y. Shir, and M. A. Ware, “Experience with the synthetic cannabinoid nabilone in chronic noncancer pain,” Pain Medicine, vol. 7, no. 1, pp. 25–29, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Hermanns-Clausen, S. Kneisel, B. Szabo, and V. Auwärter, “Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings,” Addiction, vol. 108, no. 3, pp. 534–544, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Mir, A. Obafemi, A. Young, and C. Kane, “Myocardial infarction associated with use of the synthetic cannabinoid K2,” Pediatrics, vol. 128, no. 6, pp. e1622–e1627, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. E. Bernson-Leung, L. Y. Leung, and S. Kumar, “Synthetic cannabis and acute ischemic stroke,” Journal of Stroke and Cerebrovascular Diseases, vol. 23, no. 5, pp. 1239–1241, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. G. K. Bhanushali, G. Jain, H. Fatima, L. J. Leisch, and D. Thornley-Brown, “AKI associated with synthetic cannabinoids: a case series,” Clinical Journal of the American Society of Nephrology, vol. 8, no. 4, pp. 523–526, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. K. A. Meijer, R. R. Russo, and D. V. Adhvaryu, “Smoking synthetic marijuana leads to self-mutilation requiring bilateral amputations,” Orthopedics, vol. 37, no. 4, pp. e391–e394, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. C. D. Rosenbaum, S. P. Carreiro, and K. M. Babu, “Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines,” Journal of Medical Toxicology, vol. 8, no. 1, pp. 15–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Ibrahim, F. Al-Saffar, and T. Wannenburg, “A unique case of cardiac arrest following K2 abuse,” Case Reports in Cardiology, vol. 2014, Article ID 120607, 3 pages, 2014. View at Publisher · View at Google Scholar
  13. L. Fattore and W. Fratta, “Beyond THC: the new generation of cannabinoid designer drugs,” Frontiers in Behavioral Neuroscience, vol. 5, article 60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Trecki, R. R. Gerona, and M. D. Schwartz, “Synthetic cannabinoid-related illnesses and deaths,” The New England Journal of Medicine, vol. 373, no. 2, pp. 103–107, 2015. View at Publisher · View at Google Scholar
  15. A. Gash, J. S. Karliner, D. Janowsky, and C. R. Lake, “Effects of smoking marihuana on left ventricular performance and plasma norepinephrine: studies in normal men,” Annals of Internal Medicine, vol. 89, no. 4, pp. 448–452, 1978. View at Google Scholar
  16. J. L. Weiss, A. M. Watanabe, L. Lemberger, N. R. Tamarkin, and P. V. Cardon, “Cardiovascular effects of delta-9-tetrahydrocannabinol in man,” Clinical Pharmacology & Therapeutics, vol. 13, no. 5, pp. 671–684, 1972. View at Google Scholar · View at Scopus
  17. P. F. Renault, C. R. Schuster, R. Heinrich, and D. X. Freeman, “Marihuana: standardized smoke administration and dose effect curves on heart rate in humans,” Science, vol. 174, no. 4009, pp. 589–591, 1971. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. Mittleman, M. Maclure, J. B. Sherwood et al., “Triggering of acute myocardial infarction onset by episodes of anger. Determinants of myocardial infarction onset study investigators,” Circulation, vol. 92, no. 7, pp. 1720–1725, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Kocabay, M. Yildiz, N. E. Duran, and M. Ozkan, “Acute inferior myocardial infarction due to cannabis smoking in a young man,” Journal of Cardiovascular Medicine, vol. 10, no. 9, pp. 669–670, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Bachs and H. Morland, “Acute cardiovascular fatalities following cannabis use,” Forensic Science International, vol. 124, no. 2-3, pp. 200–203, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Velibey, S. Sahin, O. Tanik, M. Keskin, O. Bolca, and M. Eren, “Acute myocardial infarction due to marijuana smoking in a young man: guilty should not be underestimated,” American Journal of Emergency Medicine, vol. 33, no. 8, pp. 1114.e1–1114.e3, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. C. J. Hodcroft, M. C. Rossiter, and A. N. Buch, “Cannabis-associated myocardial infarction in a young man with normal coronary arteries,” Journal of Emergency Medicine, vol. 47, no. 3, pp. 277–281, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. R. G. McKeever, D. Vearrier, D. Jacobs, G. LaSala, J. Okaneku, and M. I. Greenberg, “K2-not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report,” Journal of Medical Toxicology, vol. 11, no. 1, pp. 129–131, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. B. C. Clark, J. Georgekutty, and C. I. Berul, “Myocardial ischemia secondary to synthetic cannabinoid (K2) use in pediatric patients,” The Journal of Pediatrics, vol. 167, no. 3, pp. 757.e1–761.e1, 2015. View at Publisher · View at Google Scholar
  25. M. A. Mittleman, R. A. Lewis, M. Maclure, J. B. Sherwood, and J. E. Muller, “Triggering myocardial infarction by marijuana,” Circulation, vol. 103, no. 23, pp. 2805–2809, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Sztajzel, H. Karpuz, and W. Rutishauser, “Heroin abuse and myocardial infarction,” International Journal of Cardiology, vol. 47, no. 2, pp. 180–182, 1994. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Melandri, I. De Tommaso, I. Zele et al., “Myocardial involvement in rhabdomyolysis caused by acute heroin intoxication,” Recenti Progressi in Medicina, vol. 82, no. 6, pp. 324–327, 1991. View at Google Scholar · View at Scopus
  28. D. G. Ioseliani, S. P. Semitko, D. G. Gromov et al., “Development of transmural myocardial infarction in young persons with intact coronary arteries during methadone use for the treatment of heroine addiction,” Kardiologiia, vol. 44, no. 10, pp. 107–112, 2004. View at Google Scholar · View at Scopus
  29. M. Backmund, K. Meyer, W. Zwehl, O. Nagengast, and D. Eichenlaub, “Myocardial infarction associated with methadone and/or dihydrocodeine,” European Addiction Research, vol. 7, no. 1, pp. 37–39, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. E. R. Gross, A. K. Hsu, and G. J. Gross, “Acute methadone treatment reduces myocardial infarct size via the δ-opioid receptor in rats during reperfusion,” Anesthesia and Analgesia, vol. 109, no. 5, pp. 1395–1402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. G. W. Rouan, T. H. Lee, E. F. Cook, D. A. Brand, M. C. Weisberg, and L. Goldman, “Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study),” The American Journal of Cardiology, vol. 64, no. 18, pp. 1087–1092, 1989. View at Publisher · View at Google Scholar · View at Scopus
  32. B. D. McCarthy, J. B. Wong, and H. P. Selker, “Detecting acute cardiac ischemia in the emergency department: a review of the literature,” Journal of General Internal Medicine, vol. 5, no. 4, pp. 365–373, 1990. View at Publisher · View at Google Scholar · View at Scopus
  33. C. R. Harris and A. Brown, “Synthetic cannabinoid intoxication: a case series and review,” Journal of Emergency Medicine, vol. 44, no. 2, pp. 360–366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Sweeney, S. Talebi, D. Toro et al., “Hyperthermia and severe rhabdomyolysis from synthetic cannabinoids,” American Journal of Emergency Medicine, 2015. View at Publisher · View at Google Scholar
  35. E. A. Berkowitz, T. S. Henry, S. Veeraraghavan, G. W. Staton, and A. A. Gal, “Pulmonary effects of synthetic marijuana: chest radiography and CT findings,” American Journal of Roentgenology, vol. 204, no. 4, pp. 750–757, 2015. View at Publisher · View at Google Scholar
  36. S. Alhadi, A. Tiwari, R. Vohra, R. Gerona, J. Acharya, and K. Bilello, “High times, low sats: diffuse pulmonary infiltrates associated with chronic synthetic cannabinoid use,” Journal of Medical Toxicology, vol. 9, no. 2, pp. 199–206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Aksel, Ö. Güneysel, T. Taşyürek, E. Kozan, and Ş. E. Çevik, “Intravenous lipid emulsion therapy for acute synthetic cannabinoid intoxication: clinical experience in four cases,” Case Reports in Emergency Medicine, vol. 2015, Article ID 180921, 5 pages, 2015. View at Publisher · View at Google Scholar
  38. K. Schmid, N. Niederhoffer, and B. Szabo, “Analysis of the respiratory effects of cannabinoids in rats,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 368, no. 4, pp. 301–308, 2003. View at Publisher · View at Google Scholar · View at Scopus